Skip to main content
In stock | Targeted Therapy

Gandotinib

Oncology Type Hematologic (MPN)
Drug Class / Mechanism JAK Inhibitor
No Image
Description

Gandotinib is classified as a JAK Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy
Oncology Type Hematologic (MPN)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3